Sponsors

BIVDA announces interim CEO

The British In Vitro Diagnostics Association (BIVDA) has announced the appointment of Helen Dent as its interim Chief Executive Officer.

Helen has spent the last three and a half years as BIVDA’s Chief Operating Officer and has previously worked at Abbott Diagnostics and in the NHS, bringing a wealth of experience to her new role.

Helen commented: “I am very excited to take on this new role, and to lead BIVDA’s efforts in shaping policy, at an important time for our members. I am proud of the work that we have done for our members at BIVDA and look forward to continuing to work closely with them, many of which I have worked with throughout my career, both as a customer and a colleague.”

Helen will continue to drive BIVDA’s work forward, ensuring that its members’ voices are heard and amplified, and that the value of IVD testing is understood, ultimately to achieve the goal of improving patient outcomes.

 

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026